Generic Price Regulation and Drug Expenditures: Evidence From Canada
- 24 January 2023
- journal article
- research article
- Published by Elsevier BV in Value in Health
- Vol. 26 (6), 833-840
- https://doi.org/10.1016/j.jval.2023.01.008
Abstract
No abstract availableKeywords
Funding Information
- University of Nottingham Ningbo China
This publication has 17 references indexed in Scilit:
- The effect of cost on adherence to prescription medications in CanadaCMAJ : Canadian Medical Association Journal, 2012
- Patient Cost-Sharing and Hospitalization Offsets in the ElderlyThe American Economic Review, 2010
- Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation?European Economic Review, 2009
- Bootstrap-Based Improvements for Inference with Clustered ErrorsThe Review of Economics and Statistics, 2008
- Physician Awareness of Drug Cost: A Systematic ReviewPLoS Medicine, 2007
- Estimating the price elasticity of expenditure for prescription drugs in the presence of non‐linear price schedules: an illustration from Quebec, CanadaHealth Economics, 2005
- Uncertainty and Learning in Pharmaceutical DemandEconometrica, 2005
- An empirical model of learning and patient spillovers in new drug entryJournal of Econometrics, 2004
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and SpendingThe New England Journal of Medicine, 2003